Irinotecan
Links shared publicly online about this topic
APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections
usrecallnews.com — “APP Pharmaceuticals, is re recalling five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorectal cancer.” View full resource at usrecallnews.com
Most Recently Shared on March 28, 2011 at 7:42 pm By:
APP Pharmaceuticals Recalls Irinotecan Hydrochloride Injections http://f.ast.ly/ssMYY
APP Pharmaceuticals Recalls Irinotecan HCl Injection - ONA
oncologynurseadvisor.com — “APP Pharmaceuticals has issued a voluntary recall of five lots of irinotecan HCl injection due to the discovery of foreign particulate material and nonsterility in one lot.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 28, 2011 at 6:34 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
APP Pharmaceuticals Recalls Irinotecan HCl Injection http://goo.gl/fb/OlZkK
APP Pharmaceuticals Recalls Irinotecan HCl Injection - MPR
empr.com — “APP Pharmaceuticals has issued a voluntary recall of five lots of irinotecan HCl injection due to the discovery of foreign particulate material and nonsterility in one lot.” View full resource at empr.com
Most Recently Shared on March 28, 2011 at 6:48 pm By:
MPR News: APP Pharmaceuticals Recalls Irinotecan HCl Injection: APP Pharmaceuticals has issued a voluntary recal... http://bit.ly/f65ReC
FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant
drugs.com — “FDA Alert: Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant” View full resource at drugs.com
Most Recently Shared on March 29, 2011 at 1:45 am By:
FDA Alert - Recall: Irinotecan Hydrochloride Injection - Fungal Microbial Contaminant - http://bit.ly/ePzpD2
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection
medicalnewstoday.com — “APP Pharmaceuticals, Inc., (APP) announced that it has issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection, which is used for recurrent or progressive metastatic colorecta” View full resource at medicalnewstoday.com
Most Recently Shared on March 28, 2011 at 9:05 am By:
MNT Colorectal Canc Health News
APP Pharmaceuticals Issues A Nationwide Voluntary Recall Of Irinotecan Hydrochloride Injection http://mnt.to/3SNx #colorectalcancer
ingentaconnect Irinotecan: Interstitial pneumonia in an elderly patient: case re...
ingentaconnect.com — “ingentaconnect Irinotecan: Interstitial pneumonia in an elderly patient: case re...” View full resource at ingentaconnect.com
Most Recently Shared on November 10, 2010 at 7:56 am By:
Irinotecan: Interstitial pneumonia in an elderly patient: case report: (Source: Reactions) http://bit.ly/b5AWzz
ingentaconnect APP Pharmaceuticals is recalling five lots of irinotecan injectio...
ingentaconnect.com — “ingentaconnect APP Pharmaceuticals is recalling five lots of irinotecan injectio...” View full resource at ingentaconnect.com
Most Recently Shared on April 12, 2011 at 8:39 pm By:
Drugs and Devices OW OW Health
APP Pharmaceuticals is recalling five lots of irinotecan injection as a precautionary measure: (Source: Reactions) http://bit.ly/gOtwoJ
Gastro Medical News about Stomach Neoplasms Cisplatin Irinotecan
mdlinx.com — “A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer” View full resource at mdlinx.com
Most Recently Shared on February 12, 2010 at 1:20 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
GI: A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent... http://bit.ly/bO8zsg
Bevacizumab with, without irinotecan improved response, survival in recurrent glioblastoma | HemOncToday
hemonctoday.com — “Bevacizumab alone or in combination with irinotecan improved response rates, PFS and OS compared with that typically seen in patients with recur” View full resource at hemonctoday.com
Most Recently Shared on September 4, 2009 at 2:19 pm By:
HemOnc Today Oncology and Health News
Presented at #ASCO 08 http://ow.ly/o3Qb Now in JCO, bevacizumab with, without irinotecan improved survival in glioblastoma http://ow.ly/o3Qq
Addition of Dalotuzumab to Cetuximab + Irinotecan Does Not Improve Progression-Free Survival in Colorectal Cancer - ONA
oncologynurseadvisor.com — “The addition of dalotuzumab (MK-0646) to cetuximab and irinotecan failed to improve progression-free survival and overall survival in patients with chemorefractory KRAS wild-type metastatic colorectal cancer, according to study investigators at the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 5, 2011 at 2:49 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Addition of Dalotuzumab to Cetuximab + Irinotecan Does Not Improve Progression-Free Survival… http://goo.gl/fb/hPz1U
Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer
news-medical.net — “Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 3:46 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer: Jenner... http://t.co/MlO8mmVx
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant - Drugs.com MedNews
drugs.com — “AUDIENCE Oncology, Pharmacy, Risk Manager ISSUE APP Pharmaceuticals, Inc. issued a voluntary recall of five lots of Irinotecan Hydrochloride Injection due to th” View full resource at drugs.com
Most Recently Shared on March 28, 2011 at 5:06 pm By:
Drugs and Devices OW OW Health
FDA MedWatch - Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant: AUDIENCE: Oncolo... http://bit.ly/fhbqSE #drug
Medical News: ASCO GI: Mixed Results for Liposomal Irinotecan - in Meeting Coverage, ASCO GI from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- A randomized trial of liposomal irinotecan (PEP02) in gastric cancer yielded mixed results, achieving the primary objective of tumor shrinkage but without improving disease control ra” View full resource at medpagetoday.com
Most Recently Shared on January 23, 2011 at 2:40 am By:
ASCO GI: Mixed Results for Liposomal Irinotecan http://bit.ly/gLsoWU
Medical News: ASCO GI: Mixed Results for Liposomal Irinotecan - in Meeting Coverage, ASCO GI from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- A randomized trial of liposomal irinotecan (PEP02) in gastric cancer yielded mixed results, achieving the primary objective of tumor shrinkage but without improving disease control ra” View full resource at medpagetoday.com
Most Recently Shared on January 23, 2011 at 3:19 am By:
ASCO GI: Mixed Results for Liposomal Irinotecan http://bit.ly/ffcOhR
Oncology News - Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma |3982753
mdlinx.com — “Oncology Medical Article: Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma” View full resource at mdlinx.com
Most Recently Shared on March 19, 2012 at 8:07 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients wi... http://t.co/RgIU5DsA #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
usrecallnews
Be the first to know about dangerous product recalls!
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
